Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis.

[1]  M. Herzum,et al.  Coxsackievirus B3 infection leads to cell death of cardiac myocytes. , 1994, Journal of molecular and cellular cardiology.

[2]  T. N. James,et al.  Ultrastructural alterations of the conduction system in mice exhibiting sinus arrest or heart block during Coxsackievirus B3 acute myocarditis. , 1992, American heart journal.

[3]  M. Herzum,et al.  Treatment of experimental murine Coxsackie B3 myocarditis. , 1991, European Heart Journal.

[4]  W. Abelmann,et al.  Natural evolution of cardiac function, cardiac pathology and antimyosin scan in a murine myocarditis model. , 1991, Journal of the American College of Cardiology.

[5]  R. Kloner,et al.  Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis. , 1990, American heart journal.

[6]  W. Abelmann,et al.  Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. , 1990, Circulation.

[7]  J E Parrillo,et al.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.

[8]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[9]  H. Schultheiss,et al.  Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. , 1989, Circulation research.

[10]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. , 1987, The American journal of pathology.

[11]  N. Bowles,et al.  DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.

[12]  W. Abelmann,et al.  Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. , 1986, Circulation.

[13]  A. Matsumori,et al.  Effects of prednisolone on acute viral myocarditis in mice. , 1986, Journal of the American College of Cardiology.

[14]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. , 1986, The American journal of pathology.

[15]  J. Robinson,et al.  The effects of cyclosporine on acute murine Coxsackie B3 myocarditis. , 1986, Circulation.

[16]  K. Beisel,et al.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis , 1985, The Journal of experimental medicine.

[17]  Craven Pc Interaction of ketoconazole with rifampin and isoniazid. , 1985, New England Journal of Medicine.

[18]  Woodruff Jf Viral myocarditis. A review. , 1980 .

[19]  J. Mason,et al.  Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. , 1980, The American journal of cardiology.

[20]  N. Grist,et al.  Coxsackie viruses and the heart. , 1969, American heart journal.

[21]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Maisch Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. , 1986, Basic research in cardiology.